A drug that is already in clinical trials against hepatitis C virus can also prevent hepatitis E virus from replicating.
Please provide your email address to receive an email when new articles are posted on . Chronic HCV infection was associated with a 1.8-fold increased risk for pancreatic ductal adenocarcinoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results